Published in Vaccine Weekly, November 14th, 2007
Researchers from Imperial College London, who are evaluating multiple candidate vaccines designed to prevent HIV, argue that Western governments and funding agencies must commit to sharing technology and expertise with those in the developing world on a long-term basis.
The researchers have been working with local scientists in Uganda and other sites in the developing world to enable large-scale international trials of potential...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2007-11-14)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.